About Speclipse
Speclipse is a company based in Seongnam-si (South Korea) founded in 2015 was acquired by Cellreturn in November 2019.. Speclipse has raised $10.55 million across 2 funding rounds from investors including Shinhan Financial Group, Mico and MiCoBioMed. Speclipse offers products and services including Spectra-Scope®, Pico-K, and Bellus-Q. Speclipse operates in a competitive market with competitors including Bruker, Metrohm, Impedimed, Rigaku and Anvajo, among others.
- Headquarter Seongnam-si, South Korea
-
Sectors
HealthcareTechnology
-
Phone
*********
-
Website
*********
- Legal Name Speclipse, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$10.55 M (USD)
in 2 rounds
-
Latest Funding Round
$8 M (USD), Series A
Aug 19, 2021
-
Investors
Shinhan Financial Group
& 8 more
-
Employee Count
Employee Count
-
Acquired by
Cellreturn
(Nov 05, 2019)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Speclipse
Speclipse offers a comprehensive portfolio of products and services, including Spectra-Scope®, Pico-K, and Bellus-Q. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Portable tool for detecting skin cancer via laser and AI analysis.
Picosecond laser for effective skin lesion removal and therapy.
Advanced laser device for precise dermatological treatments.
Unlock access to complete
Unlock access to complete
Funding Insights of Speclipse
Speclipse has successfully raised a total of $10.55M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $8 million completed in August 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Series A — $8.0M
-
First Round
First Round
(18 Nov 2016)
- Investors Count 8
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug, 2021 | Amount | Series A - Speclipse | Valuation | Signite Partners | |
| Nov, 2016 | Amount | Seed - Speclipse | Valuation | Mega Investment , InterVest |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Speclipse
Speclipse has secured backing from 9 investors, including venture fund and institutional investors. Prominent investors backing the company include Shinhan Financial Group, Mico and MiCoBioMed. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location | |
|
Financial group
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Speclipse
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Speclipse
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Speclipse Comparisons
Competitors of Speclipse
Speclipse operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Bruker, Metrohm, Impedimed, Rigaku and Anvajo, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Diversified research instrument systems are manufactured and supplied.
|
|
| domain | founded_year | HQ Location |
Instruments for chemical analysis are developed and manufactured.
|
|
| domain | founded_year | HQ Location |
Technologies for non-invasive fluid status assessment and monitoring are developed.
|
|
| domain | founded_year | HQ Location |
XRD, XRF, SAXS, Raman, metrology, and crystallography solutions are provided.
|
|
| domain | founded_year | HQ Location |
Point-of-care solutions for laboratory diagnostics are provided by Anvajo.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Speclipse
When was Speclipse founded?
Speclipse was founded in 2015 and raised its 1st funding round 1 year after it was founded.
Where is Speclipse located?
Speclipse is headquartered in Seongnam-si, South Korea. It is registered at Seongnam-si, Gyeonggi-do, South Korea.
Is Speclipse a funded company?
Speclipse is a funded company, having raised a total of $10.55M across 2 funding rounds to date. The company's 1st funding round was a Seed of $2.55M, raised on Nov 18, 2016.
What does Speclipse do?
Speclipse was founded in 2015 and is based in Seongnam-si, South Korea. Molecular spectroscopy systems are offered for early-stage skin cancer detection within the medical diagnostics sector. A non-invasive tool utilizing laser spectroscopy and statistical algorithms has been developed to analyze tissue chemical composition in vivo. Operations focus on in-vivo laser technology for diagnostic applications in healthcare.
Who are the top competitors of Speclipse?
What products or services does Speclipse offer?
Speclipse offers Spectra-Scope®, Pico-K, and Bellus-Q.
Who are Speclipse's investors?
Speclipse has 9 investors. Key investors include Shinhan Financial Group, Mico, MiCoBioMed, Mega Investment, and Signite Partners.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.